Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...

The Cambridge-based biotech company has been trying to reduce operating expenses as it burns cash on its large pipeline.

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

The US Department of Health and Human Services announced the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

The anticipated rollout of updated Covid vaccines this fall might be at risk after a change by Health and Human Services ...

Moderna could face suspension from Britain’s pharmaceutical trade body following a string of breaches of the regulatory code. The Covid vaccine maker is due to be audited by the Prescription ...

Madrigal Pharmaceuticals reported $137.3 million in first-quarter sales for its MASH drug Rezdiffra, topping consensus ...

On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...